News | May 12, 2016

TigerConnect Healthcare Bot Set to Automate the Future of Healthcare Information Bot-driven technology puts a “care coach” in the pocket of every patient in America Opens door to auto-diagnoses, drug interaction alerts, medication reminders, billing questions, and...

News | May 16, 2016

Afferent Pharmaceuticals Presents Updated Positive Results with AF-219 from Phase 2B Chronic Cough Study at the 2016 American Thoracic Society (ATS) International Conference Treatment with AF-219 reduced cough frequency by 50% or more at 50 mg BID dose in half of...

News | May 10, 2016

Aptinyx Raises $65 Million in Series A Financing to Advance Therapies for Neurological Disorders Evanston, Ill., May 10, 2016 – Aptinyx Inc., a biopharmaceutical company developing novel modulators of the N-methyl-D-aspartate (NMDA) receptor for the treatment of...

News | May 6, 2016

Intarcia Announces Successful Cardiovascular Safety Results in Phase 3 FREEDOM-CVO Trial for ITCA 650, an Investigational Therapy for Type 2 Diabetes Company also Reports New $75 Million Financing for Manufacturing Scale-Up and Inventory Build for Anticipated Global...

News | April 28, 2016

IRHYTHM TECHNOLOGIES EXPANDS ZIO® SERVICE TO INCLUDE TRUE ATRIAL FIBRILLATION DURATION REPORTING SAN FRANCISCO, CA –April 28, 2016 –– iRhythm Technologies, Inc., a leading digital health care company focused on the advancement of cardiac care, announced today a...
leo ultricies Praesent tristique risus dictum commodo quis, consectetur vel,